CN101732408B - Chinese medicament for treating angitis and limb angiopathy and preparation method thereof - Google Patents
Chinese medicament for treating angitis and limb angiopathy and preparation method thereof Download PDFInfo
- Publication number
- CN101732408B CN101732408B CN2010100101682A CN201010010168A CN101732408B CN 101732408 B CN101732408 B CN 101732408B CN 2010100101682 A CN2010100101682 A CN 2010100101682A CN 201010010168 A CN201010010168 A CN 201010010168A CN 101732408 B CN101732408 B CN 101732408B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preparation
- fine powder
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Chinese medicament for treating angitis and limb angiopathy and a preparation method thereof. The invention adopts the technical scheme that: the Chinese medicament is prepared from the following raw material medicament in part by weight: 5 to 10 parts of ginseng, 5 to 10 parts of danshen root, 2 to 8 parts of liquoric root, 2 to 7 parts of Indian buead, 1 to 5 parts of largehead atractylodes rhizome and 1 to 3 parts of bezoar. The preparation method comprises the following steps of: crushing the ginseng, the danshen root, the liquoric root, the Indian buead and the largehead atractylodes rhizome in proportion; passing the mixture through an 80-mesh screen; drying and sterilizing the mixture to prepare fine powder; adding crushed bezoar fine powder which is sieved by using an 80-mesh screen; and uniformly mixing the mixture to prepare tablets or capsules. The Chinese medicament has the advantages of low cost, convenient administration, obvious curative effect and no relapse.
Description
Technical field
The present invention relates to the field of Chinese medicines, relate to a kind of Chinese medicine of treating vasculitis and limb angiopathy particularly.
Background technology
Vasculitis is clinical common peripheral angiopathy.The vasculitis full name is a thromboangiitis obliterans, is a kind of serious disease that causes vascular inflammation owing to arteriolar embolism in the limbs.Mostly its symptom is that limb end sends out cold, pain, tissue necrosis, thus in general treatment sing misdiagnosis and mistreatment easily, vasculitis easily and rheumatism obscure, delay treatment, serious also can amputation, bring misery to the patient.Limb angiopathy is meant other the general name of several kinds of diseases that comprises vasculitis, like atherosclerotic occlusive disease, thrombophlebitis, and Raynaud disease and Takayasu arteritis, limb angiopathy the lighter limbs pain, weight person can cause brothers' necrosis of festering.Also do not have effective medicine for treatment vasculitis and limb angiopathy at present, therapeutic effect is poor.
Summary of the invention
In order to overcome the above problems, it is low to the purpose of this invention is to provide a kind of cost, taking convenience, the treatment vasculitis evident in efficacy and the Chinese medicine of limb angiopathy.
Another object of the present invention provides a kind of preparation method of Chinese medicine of treating vasculitis and limb angiopathy.
To achieve these goals, the technical scheme of the present invention's employing is: a kind of Chinese medicine of treating vasculitis and limb angiopathy is characterized in that being processed by following raw material medicaments in part by weight proportioning:
5～10 parts of Radix Ginsengs, 5～10 parts of Radix Salviae Miltiorrhizaes,
2～8 parts in Radix Glycyrrhizae, 2～7 parts in Poria,
1～5 part of the Rhizoma Atractylodis Macrocephalae, 1～3 part of Calculus Bovis.
The above-mentioned treatment vasculitis and the preparation method of Chinese medicine of limb angiopathy are following:
By above-mentioned proportioning, with Radix Ginseng, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae, the Poria and the Rhizoma Atractylodis Macrocephalae are pulverized, and cross 80 mesh sieves, drying, fine powder is processed in sterilization; Add and pulverize the Calculus Bovis fine powder that 80 mesh sieves are crossed in the back, mix homogeneously is processed tablet or capsule.
The pharmacology of the crude drug that the present invention adopts, the property of medicine is following:
Radix Ginseng: [meridian distribution of property and flavor] sweet, little hardship, flat, return spleen, lung, heart channel.[function cures mainly] strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, and invigorating the spleen to benefit the lung promotes the production of body fluid, and calms the nerves.Be used for weak body and prostration, the cold extremities faint pulse, insufficiency of the spleen lack of appetite, the deficiency of the lung is breathed with cough, and Tianjin wound is thirsty, and interior-heat is quenched one's thirst, prolonged illness weakness with emaciation, palpitation with fear insomnia, sexual impotence cold womb; Heart failure, cardiogenic shock.
Radix Salviae Miltiorrhizae: [meridian distribution of property and flavor] hardship is slightly cold GUIXIN, Liver Channel.[function cures mainly] stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, relieving restlessness clears away heart-fire.Be used for menoxenia, amenorrhea dysmenorrhea ， lumps in the chest and abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.
Radix Glycyrrhizae: [meridian distribution of property and flavor] is sweet, and be flat.GUIXIN, lung, spleen, stomach warp.[function cures mainly] invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Poria: [meridian distribution of property and flavor] is sweet, light, and be flat, GUIXIN, lung, spleen, kidney channel.[function cures mainly] promoting diuresis to eliminate damp pathogen, the spleen invigorating mind calming.Be used for the edema oliguria, the phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, have loose bowels in the loose stool, irritability, palpitation with fear insomnia.
The Rhizoma Atractylodis Macrocephalae: [meridian distribution of property and flavor] is bitter, sweet, and temperature is returned spleen, stomach warp.[function cures mainly] invigorating the spleen and benefiting QI, the dampness diuretic, hidroschesis, antiabortive.Be used for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.The Rhizoma Atractylodis Macrocephalae spleen invigorating, stomach function regulating, antiabortive.Be used for insufficiency of the spleen lack of appetite, the loose stool of having loose bowels, frequent fetal movement.
Calculus Bovis: [meridian distribution of property and flavor] is sweet, cold., GUIXIN, Liver Channel.[function cures mainly] clears away heart-fire, and eliminating phlegm is had one's ideas straightened out, cool liver, endogenous wind stopping, detoxifcation.Be used for the calentura coma, middle wind-phlegm fan, infantile convulsion is twitched, and epilepsy is gone mad, laryngopharynx swelling and pain, aphtha of the mouth and tongue, carbuncle furuncle.
The present invention is following to vasculitis and limb vessel patient's treatment clinical observation:
(1) physical data:
Vasculitis: 235 examples
Limb angiopathy: 226 examples
(2) diagnostic criteria
Vasculitis: the terminal pain of brothers, send out cool, the local organization necrosis of festering.
Limb angiopathy: the cool fiber crops of extremity, acid is expanded, the shank edema, skin color is black, festers.
(3) Therapeutic Method
Get among the embodiment 1 capsule of processing.
Instructions of taking: take each 5～7 every day three times.
(4) efficacy assessment standard
Vasculitis
Cure: no pain, do not send out cold, the face that festers healing.
Effectively: no pain, do not send out cold, the face that festers heals gradually.
Invalid: through treatment, symptom does not change or changes less.
Limb angiopathy
Cure: sx, the face that festers healing.
Effectively: sx, the face that festers heals gradually.
Invalid: process treatment symptom does not change or changes less.
(5) therapeutic outcome (seeing table 1)
Through taking Chinese medicine of the present invention after 1 year, therapeutic outcome is as shown in table 1.
Table 1 curative effect clinical observation after treatment
The invention has the beneficial effects as follows: the present invention is guidance with the theory of Chinese medical science, and the science compatibility with 6 flavor Chinese medicine synergism, has significant curative effect to vasculitis and limb angiopathy.Through clinical observation, vasculitis patient cure rate is reached 80.8%, total effective rate is 98.7%; Limb vessel patient cure rate is reached 81.9%, and total effective rate is 100%.Through following up a case by regular visits to, there is not recurrence.
The specific embodiment:
Embodiment 1
A kind of Chinese medicine of treating vasculitis and limb angiopathy, process by weight ratio by following crude drug:
Radix Ginseng 700g, Radix Salviae Miltiorrhizae 750g,
Radix Glycyrrhizae 600g, Poria 450g,
Rhizoma Atractylodis Macrocephalae 380g, Calculus Bovis 120g.
Method for preparing is following: by above-mentioned proportioning, and with Radix Ginseng, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae, the Poria and the Rhizoma Atractylodis Macrocephalae are pulverized, and cross 80 mesh sieves, drying, fine powder is processed in sterilization; Add and pulverize the Calculus Bovis fine powder that 80 mesh sieves are crossed in the back, mix homogeneously is processed 6000 capsules.
Embodiment 2
A kind of Chinese medicine of treating vasculitis and limb angiopathy, process by weight ratio by following crude drug:
Radix Ginseng 500g, Radix Salviae Miltiorrhizae 500g,
Radix Glycyrrhizae 800g, Poria 700g,
Rhizoma Atractylodis Macrocephalae 100g, Calculus Bovis 300g.
Method for preparing is following: by above-mentioned proportioning, and with Radix Ginseng, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae, the Poria and the Rhizoma Atractylodis Macrocephalae are pulverized, and cross 80 mesh sieves, drying, fine powder is processed in sterilization; Add and pulverize the Calculus Bovis fine powder that 80 mesh sieves are crossed in the back, mix homogeneously is processed 6000 capsules.
Embodiment 3
A kind of Chinese medicine of treating vasculitis and limb angiopathy, process by weight ratio by following crude drug:
Radix Ginseng 1000g, Radix Salviae Miltiorrhizae 1000g,
Radix Glycyrrhizae 200g, Poria 200g,
Rhizoma Atractylodis Macrocephalae 500g, Calculus Bovis 100g.
Method for preparing is following: by above-mentioned proportioning, and with Radix Ginseng, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae, the Poria and the Rhizoma Atractylodis Macrocephalae are pulverized, and cross 80 mesh sieves, drying, fine powder is processed in sterilization; Add and pulverize the Calculus Bovis fine powder that 80 mesh sieves are crossed in the back, mix homogeneously is processed 6000 capsules.
Claims (2)
1. treat vasculitic Chinese medicine for one kind, it is characterized in that processing by following raw material medicaments in part by weight proportioning:
5～10 parts of Radix Ginsengs, 5～10 parts of Radix Salviae Miltiorrhizaes,
2～8 parts in Radix Glycyrrhizae, 2～7 parts in Poria,
1～5 part of the Rhizoma Atractylodis Macrocephalae, 1～3 part of Calculus Bovis.
2. the vasculitic preparation method of Chinese medicine of the described treatment of claim 1 is characterized in that comprising the steps:
By the described proportioning of claim 1, with Radix Ginseng, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae, the Poria and the Rhizoma Atractylodis Macrocephalae are pulverized, and cross 80 mesh sieves, drying, fine powder is processed in sterilization; Add and pulverize the Calculus Bovis fine powder that 80 mesh sieves are crossed in the back, mix homogeneously is processed tablet or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010100101682A CN101732408B (en) | 2010-01-21 | 2010-01-21 | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010100101682A CN101732408B (en) | 2010-01-21 | 2010-01-21 | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101732408A CN101732408A (en) | 2010-06-16 |
| CN101732408B true CN101732408B (en) | 2012-05-02 |
Family
ID=42456776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010100101682A Expired - Fee Related CN101732408B (en) | 2010-01-21 | 2010-01-21 | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101732408B (en) |
-
2010
- 2010-01-21 CN CN2010100101682A patent/CN101732408B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101732408A (en) | 2010-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN100551422C (en) | A kind of endo-medicine for the treatment of intervertebral disk hernia | |
| CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
| CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN104288631A (en) | Medicine composition for treating colon cancer and preparation method thereof | |
| CN104258304A (en) | Medicated wine for meridian unblocking, wind dispelling, collaterals activating and pain relieving | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN104547523A (en) | Medicine for enhancing immunity and preparation method thereof | |
| CN103784541A (en) | Traditional Chinese medicine for treating pains on neck, shoulders, waist and legs | |
| CN102488781A (en) | Traditional Chinese medicine composition for treating wind-damp-cold arthralgia | |
| CN101732408B (en) | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof | |
| CN102028768B (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN102872287A (en) | Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof | |
| CN102579617A (en) | Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same | |
| CN102743499A (en) | Chinese medicinal herb drug for treating soft tissue internal injury blood stasis and cerebral hemorrhage | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN102641348B (en) | Collateral-dredging and pain-relieving powder and preparation method thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101732648B (en) | Medicament for treating nonunion | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
| CN105796860A (en) | Quick-acting bone setting Yi medicine | |
| CN106138922A (en) | A kind of Chinese medicine formula treating rectal cancer | |
| CN104645244A (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
| CN102949612B (en) | A kind of preparation for being used to treat neck and lumbar pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120502 Termination date: 20130121 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |